Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

193.81 -0.78 (-0.40%)
Streaming Delayed Price Updated: 2:53 PM EDT, Sep 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,881,895
Open 194.78
Bid (Size) 193.77 (1)
Ask (Size) 193.82 (1)
Prev. Close 194.59
Today's Range 191.27 - 195.07
52wk Range 135.85 - 199.95
Shares Outstanding N/A
Dividend Yield 3.05%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. 
Via Benzinga
What the Options Market Tells Us About AbbVie
Via Benzinga

Performance

YTD
+21.27%
+21.27%
1 Month
+1.91%
+1.91%
3 Month
+16.69%
+16.69%
6 Month
+7.76%
+7.76%
1 Year
+29.84%
+29.84%

More News

Read More
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
Via Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Via Benzinga
3 Things You Need to Know if You Buy AbbVie Stock Today
Via The Motley Fool
Peering Into AbbVie's Recent Short Interest
Via Benzinga
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
Via Benzinga
AbbVie Options Trading: A Deep Dive into Market Sentiment
Via Benzinga
3 No-Brainer Dividend Stocks to Buy in September
Via The Motley Fool
Earn $1,000 Per Month in Dividends From These 4 Stocks
Via The Motley Fool
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
Via The Motley Fool
AbbVie Stock Post Humira is Still an Attractive Stock to Hold
Via MarketBeat
Topics Intellectual Property
Exposures Intellectual Property
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
Via FinancialNewsMedia
Exposures COVID-19
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
2 Dividend Stocks You Can Safely Hold Through a Recession
Via The Motley Fool
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth
From FN Media Group LLC
Via GlobeNewswire
2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer
Via The Motley Fool
Stock Market Rally Mixed; Dow Jones Hits High While Nvidia Tumbles On Earnings: Weekly Review
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
Via The Motley Fool
3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
Via The Motley Fool
2 Incredibly Cheap Healthcare Stocks to Buy Now
Via The Motley Fool
Biotech And Life Science Sector Update Summer Of 2024
Via Talk Markets
Bull Market Buys: 3 Dividend Stocks to Own for the Long Run
Via The Motley Fool
As Regulators Gear Up To Decide On Bristol Myers' Schizophrenia Treatment, Neurocrine Biosciences' Data Disappoints Investors
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.